Cubist Systematic Strategies, LLC Mirum Pharmaceuticals, Inc. Put Options Transaction History
Cubist Systematic Strategies, LLC
- $15.6 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding MIRM
# of Institutions
238Shares Held
56.2MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$440 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$308 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$210 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$181 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.56MShares$166 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.38B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...